title: Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up.
authors.forename: Hannele
authors.initials: H
authors.lastname: Virtanen
authors.forename: Anita
authors.initials: A
authors.lastname: Remitz
authors.forename: Pekka
authors.initials: P
authors.lastname: Malmberg
authors.forename: Paula
authors.initials: P
authors.lastname: Rytilä
authors.forename: Tuula
authors.initials: T
authors.lastname: Metso
authors.forename: Tari
authors.initials: T
authors.lastname: Haahtela
authors.forename: Sakari
authors.initials: S
authors.lastname: Reitamo
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus